Journal of Clinical Medicine (Jun 2022)

Continuous Renal Replacement Therapy after Liver Transplantation: Peri-Operative Associated Factors and Impact on Survival

  • Gennaro Martucci,
  • Matteo Rossetti,
  • Sergio Li Petri,
  • Rossella Alduino,
  • Riccardo Volpes,
  • Giovanna Panarello,
  • Salvatore Gruttadauria,
  • Gaetano Burgio,
  • Antonio Arcadipane

DOI
https://doi.org/10.3390/jcm11133803
Journal volume & issue
Vol. 11, no. 13
p. 3803

Abstract

Read online

Continuous renal replacement therapy (CRRT) following orthotopic liver transplantation (OLT) is usually started for multifactorial reasons, with variable incidence among series. This paper presents a single-center retrospective observational study on the early use (within one week) of CRRT after consecutive cadaveric OLT from January 2008 to December 2016. Preoperative patient characteristics and intraoperative data were collected, and patients were divided into two groups (CRRT and no CRRT) to explore the factors associated with the use of CRRT. Repeated measurements of postoperative creatinine were analyzed with generalized estimating equation (GEE) models. Among 528 OLT patients, 75 (14.2%) were treated with CRRT at least once in the first week. Patients treated with CRRT showed lower survival in a Kaplan–Meier curve (log-rank p value p values p value p value < 0.001. The early use of CRRT after OLT occurred at a low rate in this large cohort; however, it was associated with worse outcomes. Apart from the preoperative severity, repeated intraoperative hypotension episodes, which were likely modifiable or preventable, were associated with the increased use of CRRT and higher postoperative creatinine.

Keywords